JSFC Sistema in November increased its stake in a pharmaceutical company from 50% to 100%, the corporation reported in its 2024 financial statements, without specifying the name of the company. Sistema's press service explained to Interfax that the company in question is Nyarmedik, a manufacturer of cagocel. Niarmedik includes production sites in Obninsk and Mosalsk, a medical devices manufacturing plant in Italy and a network of medical clinics in Moscow, Obninsk and Ryazan.